Ahmet Salih Tüzen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ahmet Salih Tüzen has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Murat Aksun
Department of Intensive Care, Izmir Katip Celebi University Atatürk Training and Research Hospital, Izmir, Turkey
5 shared publications- Gizem Kırbaş
UNIVERSITY OF HEALTH SCIENCES, ANKARA KEÇİÖREN EDUCATION AND RESEARCH HOSPITAL
4 shared publications Senem Girgin
Department of Anesthesiology and Reanimation, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey
4 shared publications- Bülent Meriç Çam
Amasya Üniversitesi Sabuncuoğlu Şerefeddin Eğitim Araştırma Hastanesi
3 shared publications Gizem Kırbaş
Department of Anesthesiology and Reanimation, Health Science University, Bozyaka Educational and Research Hospital, Izmir, Turkey
3 shared publications- Muhammet Aydın Akdoğan
Amasya Üniversitesi Sabuncuoğlu Şerefeddin Eğitim Araştırma Hastanesi
3 shared publications
Latest Publications
- Open Access
- 19 September 2026
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 9 (5) , 1205-1211
Postoperative residual neuromuscular blockade after rocuronium: incidence and association with quantitative monitoring-a retrospective study
Aims: In this retrospective observational cohort study, we estimated the incidence of postoperative residual neuromuscular blockade (RNMB) after rocuronium administration and examined its association with intraoperative quantitative neuromuscular monitoring (NMM) and reversal strategies. Methods: We analyzed 305 adults with American Society of Anesthesiologists (ASA) physical status I-III who received rocuronium under general anesthesia between January and April 2024. Patients were classified as monitored or unmonitored according to the attending anesthesiologist’s preference for NMM use. Train-of-four ratio (TOFR) was measured in the post-anesthesia care unit (PACU) using TOFscan® acceleromyography; RNMB was defined as TOFR
- 19 September 2026
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 9 (5) , 1205-1211
Open AccessPostoperative residual neuromuscular blockade after rocuronium: incidence and association with quantitative monitoring-a retrospective study
Aims: In this retrospective observational cohort study, we estimated the incidence of postoperative residual neuromuscular blockade (RNMB) after rocuronium administration and examined its association with intraoperative quantitative neuromuscular monitoring (NMM) and reversal strategies. Methods: We analyzed 305 adults with American Society of Anesthesiologists (ASA) physical status I-III who received rocuronium under general anesthesia between January and April 2024. Patients were classified as monitored or unmonitored according to the attending anesthesiologist’s preference for NMM use. Train-of-four ratio (TOFR) was measured in the post-anesthesia care unit (PACU) using TOFscan® acceleromyography; RNMB was defined as TOFR
- Open Access
- 19 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7276
Recovery Profiles After MOAA/S-Guided Remifentanil- Versus Fentanyl-Based Propofol Sedation for Gastrointestinal Endoscopy: An IPTW-Adjusted Retrospective Cohort Study
Background/Objectives: In high-volume gastrointestinal (GI) endoscopy units, the choice of opioid adjunct may influence awakening, post-anesthesia care unit (PACU) utilization, concomitant sedative requirements, and early cardiorespiratory events. Remifentanil has a rapid and predictable offset, whereas fentanyl may produce more prolonged residual effects. We compared postanesthetic recovery after remifentanil- versus fentanyl-based propofol sedation in routine clinical practice. Methods: This single-center retrospective cohort study included adults undergoing elective upper GI endoscopy, colonoscopy, or combined procedures under anesthesiologist-directed propofol-based sedation between 1 July 2025 and 31 January 2026. Sedation was administered according to an institutional protocol targeting a Modified Observer’s Assessment of Alertness/Sedation (MOAA/S) score of 2–3. Patients received either remifentanil or fentanyl as the opioid adjunct. The primary outcome was the interval from procedure completion to the first documented response to verbal command or purposeful awakening. Secondary outcomes included procedure and anesthesia durations, PACU length of stay, propofol and midazolam doses, and early respiratory and hemodynamic events. Stabilized inverse probability of treatment weighting (IPTW) was used to balance measured baseline characteristics. Results: Among 545 patients, 280 received fentanyl and 265 received remifentanil. All assessed covariates achieved acceptable balance after weighting. Median MOAA/S score was 2 [2-2] in both groups before and after IPTW adjustment, and target-range, deeper-than-target, and lighter-than-target MOAA/S categories did not differ significantly between groups. Weighted mean recovery time was shorter with remifentanil than with fentanyl (22.6 vs. 34.1 s; adjusted mean difference, −11.4 s; 95% CI, −13.4 to −9.5; p < 0.001). Remifentanil-based sedation was also associated with shorter procedure and anesthesia durations, shorter PACU length of stay, and lower propofol and midazolam doses; these findings remained significant after false discovery rate (FDR) adjustment. No respiratory, hemodynamic, or PACU adverse outcome differed significantly after multiplicity adjustment. Conclusions: Remifentanil-based propofol sedation was associated with shorter time to first purposeful response, shorter PACU stay, and lower concomitant sedative exposure than fentanyl-based sedation during routine GI endoscopy. Documented MOAA/S findings did not show a higher frequency of lighter-than-target clinically assessed sedation in the remifentanil group. These findings may reflect the combined contribution of remifentanil’s rapid offset and lower concomitant sedative exposure, but they should be interpreted as associations within a clinician-directed sedation strategy. The retrospective, nonrandomized design precludes causal or safety-equivalence conclusions.
- 19 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7276
Open AccessRecovery Profiles After MOAA/S-Guided Remifentanil- Versus Fentanyl-Based Propofol Sedation for Gastrointestinal Endoscopy: An IPTW-Adjusted Retrospective Cohort Study
Background/Objectives: In high-volume gastrointestinal (GI) endoscopy units, the choice of opioid adjunct may influence awakening, post-anesthesia care unit (PACU) utilization, concomitant sedative requirements, and early cardiorespiratory events. Remifentanil has a rapid and predictable offset, whereas fentanyl may produce more prolonged residual effects. We compared postanesthetic recovery after remifentanil- versus fentanyl-based propofol sedation in routine clinical practice. Methods: This single-center retrospective cohort study included adults undergoing elective upper GI endoscopy, colonoscopy, or combined procedures under anesthesiologist-directed propofol-based sedation between 1 July 2025 and 31 January 2026. Sedation was administered according to an institutional protocol targeting a Modified Observer’s Assessment of Alertness/Sedation (MOAA/S) score of 2–3. Patients received either remifentanil or fentanyl as the opioid adjunct. The primary outcome was the interval from procedure completion to the first documented response to verbal command or purposeful awakening. Secondary outcomes included procedure and anesthesia durations, PACU length of stay, propofol and midazolam doses, and early respiratory and hemodynamic events. Stabilized inverse probability of treatment weighting (IPTW) was used to balance measured baseline characteristics. Results: Among 545 patients, 280 received fentanyl and 265 received remifentanil. All assessed covariates achieved acceptable balance after weighting. Median MOAA/S score was 2 [2-2] in both groups before and after IPTW adjustment, and target-range, deeper-than-target, and lighter-than-target MOAA/S categories did not differ significantly between groups. Weighted mean recovery time was shorter with remifentanil than with fentanyl (22.6 vs. 34.1 s; adjusted mean difference, −11.4 s; 95% CI, −13.4 to −9.5; p < 0.001). Remifentanil-based sedation was also associated with shorter procedure and anesthesia durations, shorter PACU length of stay, and lower propofol and midazolam doses; these findings remained significant after false discovery rate (FDR) adjustment. No respiratory, hemodynamic, or PACU adverse outcome differed significantly after multiplicity adjustment. Conclusions: Remifentanil-based propofol sedation was associated with shorter time to first purposeful response, shorter PACU stay, and lower concomitant sedative exposure than fentanyl-based sedation during routine GI endoscopy. Documented MOAA/S findings did not show a higher frequency of lighter-than-target clinically assessed sedation in the remifentanil group. These findings may reflect the combined contribution of remifentanil’s rapid offset and lower concomitant sedative exposure, but they should be interpreted as associations within a clinician-directed sedation strategy. The retrospective, nonrandomized design precludes causal or safety-equivalence conclusions.
- Open Access
- 25 April 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Association of reduced physician requirements with brain death confirmation pathway duration and organ donation outcomes in the ICU: a retrospective cohort study
Timely and accurate determination of brain death is important for donor evaluation and coordination. Prolonged diagnostic intervals may affect operational efficiency in donor evaluation and coordination, although their physiologic consequences are not uniform. In 2014, Turkey amended its legislation to reduce the number of physicians required to confirm brain death from four to two. This study evaluates the impact of this legislative change on diagnostic timing and organ donation-related outcomes in a tertiary intensive care unit (ICU). We conducted a single-center retrospective cohort study including adult ICU patients with legally confirmed brain death between 2007 and 2019. Patients were categorized into pre-amendment (before 2014) and post-amendment (2014 onward) cohorts according to the period of diagnosis. The primary outcome was the time from first documented ICU suspicion of brain death to legal confirmation. Secondary outcomes included the time from first documented suspicion to cardiac arrest in non-donor patients, organ donation status, and reasons for non-donation. A total of 322 patients with legally confirmed brain death were included (166 patients in the post-amendment period and 156 patients in the pre-amendment period). The median time from first documented ICU suspicion of brain death to legal confirmation was significantly shorter after the legislative amendment (44.6 [IQR 38.7–60.6] vs. 61.4 [IQR 50.3–75.6] hours; p < 0.001). In adjusted quantile regression analysis controlling for age, sex, etiology of brain death, and calendar year, the pre-amendment period remained independently associated with a longer confirmation pathway (adjusted median difference 14.6 h, 95% CI 9.9–19.3). Reduction in the number of physicians required for legal confirmation of brain death was associated with a substantial shortening of the clinical-administrative pathway from first documented ICU suspicion to confirmation. However, this process improvement did not translate into higher organ donation rates. Persistent family refusal suggests that procedural streamlining alone is insufficient to improve donation outcomes. Not applicable.
- 25 April 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Open AccessAssociation of reduced physician requirements with brain death confirmation pathway duration and organ donation outcomes in the ICU: a retrospective cohort study
Timely and accurate determination of brain death is important for donor evaluation and coordination. Prolonged diagnostic intervals may affect operational efficiency in donor evaluation and coordination, although their physiologic consequences are not uniform. In 2014, Turkey amended its legislation to reduce the number of physicians required to confirm brain death from four to two. This study evaluates the impact of this legislative change on diagnostic timing and organ donation-related outcomes in a tertiary intensive care unit (ICU). We conducted a single-center retrospective cohort study including adult ICU patients with legally confirmed brain death between 2007 and 2019. Patients were categorized into pre-amendment (before 2014) and post-amendment (2014 onward) cohorts according to the period of diagnosis. The primary outcome was the time from first documented ICU suspicion of brain death to legal confirmation. Secondary outcomes included the time from first documented suspicion to cardiac arrest in non-donor patients, organ donation status, and reasons for non-donation. A total of 322 patients with legally confirmed brain death were included (166 patients in the post-amendment period and 156 patients in the pre-amendment period). The median time from first documented ICU suspicion of brain death to legal confirmation was significantly shorter after the legislative amendment (44.6 [IQR 38.7–60.6] vs. 61.4 [IQR 50.3–75.6] hours; p < 0.001). In adjusted quantile regression analysis controlling for age, sex, etiology of brain death, and calendar year, the pre-amendment period remained independently associated with a longer confirmation pathway (adjusted median difference 14.6 h, 95% CI 9.9–19.3). Reduction in the number of physicians required for legal confirmation of brain death was associated with a substantial shortening of the clinical-administrative pathway from first documented ICU suspicion to confirmation. However, this process improvement did not translate into higher organ donation rates. Persistent family refusal suggests that procedural streamlining alone is insufficient to improve donation outcomes. Not applicable.
- Open Access
- 28 December 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Anaesthesia management and perioperative clinical outcomes in caesarean section patients with placental pathology: a retrospective cohort study
Placental pathologies, particularly placenta accreta spectrum (PAS) disorders and placenta previa, are major causes of maternal morbidity and mortality, la
- 28 December 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Open AccessAnaesthesia management and perioperative clinical outcomes in caesarean section patients with placental pathology: a retrospective cohort study
Placental pathologies, particularly placenta accreta spectrum (PAS) disorders and placenta previa, are major causes of maternal morbidity and mortality, la
- Open Access
- 17 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (42) , e45307
Safety of percutaneous tracheostomy in critically ill COVID-19 patients: A retrospective observational study
Percutaneous tracheostomy is commonly performed in intensive care unit (ICU) for patients requiring prolonged mechanical ventilation. The coronavirus disease-19 (COVID-19) pandemic raised concerns about potential complications during tracheostomy, particularly in critically ill patients with severe hypoxemia, coagulopathy, and procedural risks in infected patients. This study aimed to compare early and late complications of tracheostomy in ICU patients with and without COVID-19, and to assess the relationship between these complications, patient comorbidities, and antiplatelet/anticoagulant medication use. We conducted a retrospective cohort analysis of 132 ICU patients who underwent percutaneous tracheostomy between January 2019 and May 2021. Based on COVID-19 infection status, patients were assigned to either the COVID-19 group (Group-C) or the non-COVID-19 group (Group-NC). Data on demographics, comorbidities, medications, procedure details, and early/late complications were collected. A multivariable logistic regression model was used to assess associations between COVID-19 status and early complications, adjusting for confounding factors. A total of 132 patients were analyzed, including 33 in Group-C and 99 in Group-NC. Cannula insertion time was shorter in Group-C (6.1 ± 2.3 vs 7.3 ± 4.1 minutes, P = .031). No major bleeding or esophageal injuries were reported. Minor bleeding occurred in 9.1% of Group-C and 17.2% of Group-NC ( P > .05). Although hypoxia was observed only in Group-NC, this difference was not statistically significant. Late complications, including tracheal stenosis and tracheoesophageal fistulas, were rare and showed no significant group differences. Use of antiplatelet or anticoagulant therapy was significantly higher in Group-C (90.9% vs 27.3%, P < .001), but was not associated with increased bleeding complications. Percutaneous tracheostomy appears to be equally safe in COVID-19 and non-COVID-19 ICU patients, even in the setting of higher anticoagulant and antiplatelet therapy. These findings support the continued feasibility and safety of tracheostomy in both populations when performed under appropriate precautions.
- 17 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (42) , e45307
Open AccessSafety of percutaneous tracheostomy in critically ill COVID-19 patients: A retrospective observational study
Percutaneous tracheostomy is commonly performed in intensive care unit (ICU) for patients requiring prolonged mechanical ventilation. The coronavirus disease-19 (COVID-19) pandemic raised concerns about potential complications during tracheostomy, particularly in critically ill patients with severe hypoxemia, coagulopathy, and procedural risks in infected patients. This study aimed to compare early and late complications of tracheostomy in ICU patients with and without COVID-19, and to assess the relationship between these complications, patient comorbidities, and antiplatelet/anticoagulant medication use. We conducted a retrospective cohort analysis of 132 ICU patients who underwent percutaneous tracheostomy between January 2019 and May 2021. Based on COVID-19 infection status, patients were assigned to either the COVID-19 group (Group-C) or the non-COVID-19 group (Group-NC). Data on demographics, comorbidities, medications, procedure details, and early/late complications were collected. A multivariable logistic regression model was used to assess associations between COVID-19 status and early complications, adjusting for confounding factors. A total of 132 patients were analyzed, including 33 in Group-C and 99 in Group-NC. Cannula insertion time was shorter in Group-C (6.1 ± 2.3 vs 7.3 ± 4.1 minutes, P = .031). No major bleeding or esophageal injuries were reported. Minor bleeding occurred in 9.1% of Group-C and 17.2% of Group-NC ( P > .05). Although hypoxia was observed only in Group-NC, this difference was not statistically significant. Late complications, including tracheal stenosis and tracheoesophageal fistulas, were rare and showed no significant group differences. Use of antiplatelet or anticoagulant therapy was significantly higher in Group-C (90.9% vs 27.3%, P < .001), but was not associated with increased bleeding complications. Percutaneous tracheostomy appears to be equally safe in COVID-19 and non-COVID-19 ICU patients, even in the setting of higher anticoagulant and antiplatelet therapy. These findings support the continued feasibility and safety of tracheostomy in both populations when performed under appropriate precautions.
- 13 October 2025
- Published by Hitit University in Hitit Medical Journal
- Vol. 7 (3) , 442-452
Advancing Trends in Electroencephalography Monitoring in Anesthesia: A Bibliometric Analysis from 1980 to 2024
This study examines research trends, productivity, and global academic collaborations related to electroencephalography (EEG) monitoring in anesthesia management. Articles published between 1980 and 2024 were analyzed using bibliometric methods in the Web of Science database. A total of 3,371 articles were identified, with anesthesiology, neuroscience, and clinical neurology being the most active areas. The United States (865 articles) and Germany (433 articles) were the leading contributors. The number of articles strongly correlated with economic indicators such as Gross Domestic Product-Purchasing Power Parity (GDP-PPP) (r=0.885, p
- 13 October 2025
- Published by Hitit University in Hitit Medical Journal
- Vol. 7 (3) , 442-452
Advancing Trends in Electroencephalography Monitoring in Anesthesia: A Bibliometric Analysis from 1980 to 2024
This study examines research trends, productivity, and global academic collaborations related to electroencephalography (EEG) monitoring in anesthesia management. Articles published between 1980 and 2024 were analyzed using bibliometric methods in the Web of Science database. A total of 3,371 articles were identified, with anesthesiology, neuroscience, and clinical neurology being the most active areas. The United States (865 articles) and Germany (433 articles) were the leading contributors. The number of articles strongly correlated with economic indicators such as Gross Domestic Product-Purchasing Power Parity (GDP-PPP) (r=0.885, p
- Open Access
- 29 September 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 25 (1) , 1-9
Comparison of interscalene block versus shoulder anterior capsule block for postoperative pain management in rotator cuff surgery: a randomized controlled trial
Interscalene (ISC) block is the gold standard for regional anesthesia in shoulder surgery but can cause phrenic nerve involvement and motor weakness. The shoulder anterior capsule (SHAC) block has emerged as a potential alternative with motor-sparing benefits. This study compared their analgesic efficacy and motor preservation in arthroscopic rotator cuff repair. In a single-center, single-blinded, randomized controlled trial, 46 adult patients (ASA I–III) who underwent arthroscopic rotator cuff repair were assigned to receive either an ultrasound-guided ISC block (n = 23) or SHAC block (n = 23), followed by general anesthesia. The primary outcome was the pain score at the 8th postoperative hour. The secondary outcomes included motor strength, opioid consumption, intraoperative fentanyl requirement, and satisfaction scores. 40 participants (ISC = 20, SHAC = 20) were included in the final analysis. The ISC group had significantly lower pain scores at 1, 2, 4, 8, 12, 16, and 24 h postoperatively (p < 0.05). Motor function was better preserved in the SHAC group during the first 4 h postoperatively, with median (25th − 75th percentile) elbow strength scores of 2.0 (1.25–2.75) at 1 h and 3.0 (3, 4) at 4 h, compared with 0.0 (0–1) and 1.0 (0.25–2.75) in the ISC group, respectively (p < 0.01). However, no significant differences were observed beyond 8 h. Intraoperative fentanyl consumption was higher in the SHAC group (105 [100–150] mcg) than in the ISC group (50 [50–50] mcg), and 24-hour postoperative fentanyl use was also greater in the SHAC group (140 [82.5–170] mcg vs. 5 [0–27.5] mcg; both p < 0.001). Patient satisfaction at 24 h was lower in the SHAC group (4.0 [3.25–5.0]) compared with the ISC group (5.0 [5–5]; p = 0.001), whereas surgeon satisfaction was similar between the groups. Although SHAC block preserves shoulder motor function, it provides less effective analgesia and requires more opioids, which is associated with lower patient satisfaction. Number: NCT06827912 Date when the study was first posted on ClinicalTrials.gov: 02/10/2025 Date of enrollment of the first research participant: 02/20/2025
- 29 September 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 25 (1) , 1-9
Open AccessComparison of interscalene block versus shoulder anterior capsule block for postoperative pain management in rotator cuff surgery: a randomized controlled trial
Interscalene (ISC) block is the gold standard for regional anesthesia in shoulder surgery but can cause phrenic nerve involvement and motor weakness. The shoulder anterior capsule (SHAC) block has emerged as a potential alternative with motor-sparing benefits. This study compared their analgesic efficacy and motor preservation in arthroscopic rotator cuff repair. In a single-center, single-blinded, randomized controlled trial, 46 adult patients (ASA I–III) who underwent arthroscopic rotator cuff repair were assigned to receive either an ultrasound-guided ISC block (n = 23) or SHAC block (n = 23), followed by general anesthesia. The primary outcome was the pain score at the 8th postoperative hour. The secondary outcomes included motor strength, opioid consumption, intraoperative fentanyl requirement, and satisfaction scores. 40 participants (ISC = 20, SHAC = 20) were included in the final analysis. The ISC group had significantly lower pain scores at 1, 2, 4, 8, 12, 16, and 24 h postoperatively (p < 0.05). Motor function was better preserved in the SHAC group during the first 4 h postoperatively, with median (25th − 75th percentile) elbow strength scores of 2.0 (1.25–2.75) at 1 h and 3.0 (3, 4) at 4 h, compared with 0.0 (0–1) and 1.0 (0.25–2.75) in the ISC group, respectively (p < 0.01). However, no significant differences were observed beyond 8 h. Intraoperative fentanyl consumption was higher in the SHAC group (105 [100–150] mcg) than in the ISC group (50 [50–50] mcg), and 24-hour postoperative fentanyl use was also greater in the SHAC group (140 [82.5–170] mcg vs. 5 [0–27.5] mcg; both p < 0.001). Patient satisfaction at 24 h was lower in the SHAC group (4.0 [3.25–5.0]) compared with the ISC group (5.0 [5–5]; p = 0.001), whereas surgeon satisfaction was similar between the groups. Although SHAC block preserves shoulder motor function, it provides less effective analgesia and requires more opioids, which is associated with lower patient satisfaction. Number: NCT06827912 Date when the study was first posted on ClinicalTrials.gov: 02/10/2025 Date of enrollment of the first research participant: 02/20/2025
- Open Access
- 5 August 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (15) , 1962
The Effect of Obesity and General Anaesthesia Mode on the Frontal QRS-T Angle During Laparoscopic Surgery
Background/Objectives: Obesity is a major cause of repolarisation defects of the heart. The frontal QRS-T angle is a new parameter used for cardiac evaluation. This study aimed to evaluate the effects of a laparoscopic cholecystectomy and anaesthetic agents on the frontal QRS-T angle in individuals with obesity. Methods: A total of 91 patients who underwent a laparoscopic cholecystectomy surgery were included in this study. The patients were divided into two groups according to body mass index (BMI) < 30 (n = 68) and ≥30 (n = 23). The frontal QRS-T angle (FQRST), QT interval (QT), corrected QT, and other electrocardiography (ECG) findings were recorded at different time points. Results: In the BMI ≥ 30 group, the frontal QRS-T angle and QT interval measured during the intraoperative period were statistically higher than those of the BMI < 30 group (p < 0.001, p < 0.001). Additionally, the frontal QRS-T angle value was statistically higher in all patients postoperatively compared with the preoperative and intraoperative periods (p < 0.001). Furthermore, there was a positive correlation between the BMI and the frontal QRS-T angle. Our study found that the QRS-T angle and the QT interval duration measured during surgery in the BMI ≥ 30 group who underwent a laparoscopic cholecystectomy were significantly higher than in the BMI < 30 group. Conclusions: We recommend close haemodynamic monitoring during and after surgery for patients with obesity undergoing a laparoscopic cholecystectomy.
- 5 August 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (15) , 1962
Open AccessThe Effect of Obesity and General Anaesthesia Mode on the Frontal QRS-T Angle During Laparoscopic Surgery
Background/Objectives: Obesity is a major cause of repolarisation defects of the heart. The frontal QRS-T angle is a new parameter used for cardiac evaluation. This study aimed to evaluate the effects of a laparoscopic cholecystectomy and anaesthetic agents on the frontal QRS-T angle in individuals with obesity. Methods: A total of 91 patients who underwent a laparoscopic cholecystectomy surgery were included in this study. The patients were divided into two groups according to body mass index (BMI) < 30 (n = 68) and ≥30 (n = 23). The frontal QRS-T angle (FQRST), QT interval (QT), corrected QT, and other electrocardiography (ECG) findings were recorded at different time points. Results: In the BMI ≥ 30 group, the frontal QRS-T angle and QT interval measured during the intraoperative period were statistically higher than those of the BMI < 30 group (p < 0.001, p < 0.001). Additionally, the frontal QRS-T angle value was statistically higher in all patients postoperatively compared with the preoperative and intraoperative periods (p < 0.001). Furthermore, there was a positive correlation between the BMI and the frontal QRS-T angle. Our study found that the QRS-T angle and the QT interval duration measured during surgery in the BMI ≥ 30 group who underwent a laparoscopic cholecystectomy were significantly higher than in the BMI < 30 group. Conclusions: We recommend close haemodynamic monitoring during and after surgery for patients with obesity undergoing a laparoscopic cholecystectomy.
- 25 March 2025
- Published by Wiley in Transfusion
- Vol. 65 (5) , 863-875
Assessment of oxygen extraction rate changes following red blood cell transfusion in the intensive care unit: A prospective observational noninterventional study
Background: The decision‐making process for red blood cell transfusion (RBCT) in critically ill patients in the intensive care unit (ICU) remains primarily guided by hemoglobin‐based thresholds. However, as a component of personalized medicine, innovative and individualized criteria should be developed to optimize RBCT decisions. This study aims to assess the impact of RBCTs on oxygenation parameters and patient outcomes, with a specific focus on the oxygen extraction ratio (O2ER).Study Design and Methods: This prospective observational study included 77 critically ill patients receiving RBCTs according to ICU transfusion protocols. The primary hypothesis is that patients with an O2ER > 0.30 will benefit most from RBCTs. To investigate this, patients receiving RBCTs were divided into two groups: those with O2ER > 0.30 (RBCTs appropriate) and those with O2ER ≤ 0.30 (RBCTs appropriateness questionable). The two groups were compared in terms of primarily O2ER, other oxygenation parameters, and clinical outcomes. The primary outcome was the change in O2ER following RBCTs, while secondary outcomes encompassed other oxygenation parameter changes.Results: The O2ER > 0.30 group showed significant improvement in O2ER (0.38 ± 0.04 vs. 0.32 ± 0.05; p < .001), whereas no such improvement was observed in the O2ER ≤ 0.30 group (0.26 ± 0.03 vs. 0.28 ± 0.05; p: .017). Additionally, the O2ER > 0.30 group exhibited improvements in central venous oxygen saturation (ScvO2) following RBCTs, which were not seen in the O2ER ≤ 0.30 group.Discussion: Our study reveals promising insights into the impact of RBCTs on O2ER; however, these physiological changes did not result in significant clinical improvements. Hence, this study provides a rational basis for the feasibility of implementing a personalized strategy focused on physiological triggers for RBCTs. Trial registration number: NCT05798130 (https://clinicaltrials.gov/study/NCT05798130).
- 25 March 2025
- Published by Wiley in Transfusion
- Vol. 65 (5) , 863-875
Assessment of oxygen extraction rate changes following red blood cell transfusion in the intensive care unit: A prospective observational noninterventional study
Background: The decision‐making process for red blood cell transfusion (RBCT) in critically ill patients in the intensive care unit (ICU) remains primarily guided by hemoglobin‐based thresholds. However, as a component of personalized medicine, innovative and individualized criteria should be developed to optimize RBCT decisions. This study aims to assess the impact of RBCTs on oxygenation parameters and patient outcomes, with a specific focus on the oxygen extraction ratio (O2ER).Study Design and Methods: This prospective observational study included 77 critically ill patients receiving RBCTs according to ICU transfusion protocols. The primary hypothesis is that patients with an O2ER > 0.30 will benefit most from RBCTs. To investigate this, patients receiving RBCTs were divided into two groups: those with O2ER > 0.30 (RBCTs appropriate) and those with O2ER ≤ 0.30 (RBCTs appropriateness questionable). The two groups were compared in terms of primarily O2ER, other oxygenation parameters, and clinical outcomes. The primary outcome was the change in O2ER following RBCTs, while secondary outcomes encompassed other oxygenation parameter changes.Results: The O2ER > 0.30 group showed significant improvement in O2ER (0.38 ± 0.04 vs. 0.32 ± 0.05; p < .001), whereas no such improvement was observed in the O2ER ≤ 0.30 group (0.26 ± 0.03 vs. 0.28 ± 0.05; p: .017). Additionally, the O2ER > 0.30 group exhibited improvements in central venous oxygen saturation (ScvO2) following RBCTs, which were not seen in the O2ER ≤ 0.30 group.Discussion: Our study reveals promising insights into the impact of RBCTs on O2ER; however, these physiological changes did not result in significant clinical improvements. Hence, this study provides a rational basis for the feasibility of implementing a personalized strategy focused on physiological triggers for RBCTs. Trial registration number: NCT05798130 (https://clinicaltrials.gov/study/NCT05798130).
- Open Access
- 30 April 2024
- Published by Springer Nature in European Journal of Medical Research
- Vol. 29 (1) , 1-6
The effect of preoperative TSH levels on perioperative complications in patients undergoing pituitary surgery
Introduction: Pituitary surgery involves special conditions for the anaesthetist due to the anatomical localisation and the role of the pituitary gland in hormonal balance. The aim of this study was to retrospectively investigate the effect of TSH levels on perioperative complication rates in patients undergoing pituitary surgery. Methods: In this study, patients who underwent pituitary surgery at Izmir Katip Celebi University Ataturk Training and Research Hospital between January 2017 and November 2022 were retrospectively screened. Two patients out of the 137 were excluded from the study as they underwent simultaneous aneurysm surgery along with pituitary tumor surgery. A total of 135 patients meeting the criteria were analyzed. Patients were divided into three groups according to TSH levels. Perioperative complication rates and mortality rates were compared between the three groups. Findings: The study included a total of 135 patients, with an age range of 16–76 years. Among the groups with low–normal–high TSH levels, there were no statistically significant difference observed, in postoperative complications, such as epistaxis, rhinorrhea, postoperative nausea/vomiting, seizures, hypertension, and hypotension. When looking at the incidence of postoperative diabetes insipidus, a significant difference was found between the groups. When examining the mortality rates on the 28th day, a significant difference was found between the groups, with a mortality rate of 25% in the high TSH group (p < 0.5). Conclusions: The risk of perioperative mortality is higher in patients with TSH levels above normal.
- 30 April 2024
- Published by Springer Nature in European Journal of Medical Research
- Vol. 29 (1) , 1-6
Open AccessThe effect of preoperative TSH levels on perioperative complications in patients undergoing pituitary surgery
Introduction: Pituitary surgery involves special conditions for the anaesthetist due to the anatomical localisation and the role of the pituitary gland in hormonal balance. The aim of this study was to retrospectively investigate the effect of TSH levels on perioperative complication rates in patients undergoing pituitary surgery. Methods: In this study, patients who underwent pituitary surgery at Izmir Katip Celebi University Ataturk Training and Research Hospital between January 2017 and November 2022 were retrospectively screened. Two patients out of the 137 were excluded from the study as they underwent simultaneous aneurysm surgery along with pituitary tumor surgery. A total of 135 patients meeting the criteria were analyzed. Patients were divided into three groups according to TSH levels. Perioperative complication rates and mortality rates were compared between the three groups. Findings: The study included a total of 135 patients, with an age range of 16–76 years. Among the groups with low–normal–high TSH levels, there were no statistically significant difference observed, in postoperative complications, such as epistaxis, rhinorrhea, postoperative nausea/vomiting, seizures, hypertension, and hypotension. When looking at the incidence of postoperative diabetes insipidus, a significant difference was found between the groups. When examining the mortality rates on the 28th day, a significant difference was found between the groups, with a mortality rate of 25% in the high TSH group (p < 0.5). Conclusions: The risk of perioperative mortality is higher in patients with TSH levels above normal.